A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for COVID-19 or Pneumonia

Project: Research project

Project Details

StatusActive
Effective start/end date5/1/244/30/29

Funding

  • Cantex Pharmaceuticals Inc: $13,256.92